Home LiteratureArticle Details
PMID: 8497059 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

The vaccinia virus 14-kilodalton fusion protein forms a stable complex with the processed protein encoded by the vaccinia virus A17L gene.

Journal of virology ·Vol. 67 ·No. 6 ·1993-06-00 ·Pages 3435-40

Rodriguez D, Rodriguez JR, Esteban M

Abstract

The mechanism by which the 14-kDa fusion protein of vaccinia virus (VV) is anchored in the envelope of intracellular naked virions (INV) is not understood. In this investigation, we demonstrate that the 14-kDa protein interacts with another virus protein with an apparent molecular mass of 21 kDa. Microsequence analysis of the N terminus of the 21-kDa protein revealed that this protein is encoded by the VV A17L gene. The 21-kDa protein is processed from a 23-kDa precursor, by cleavage at amino acid position 16, at the consensus motif Ala-Gly-Ala, previously identified as a cleavage site for several VV structural proteins. The 21-kDa protein contains two large internal hydrophobic domains characteristic of membrane proteins. Pulse-chase analysis showed that within 1 h after synthesis, the 14-kDa protein forms a stable complex with the 21-kDa protein. Formation of the complex was not inhibited by rifampin, indicating that the interaction between these two proteins occurs prior to virion morphogenesis. Immunoprecipitation analysis of disrupted virions showed the presence of the 21-kDa protein in the viral particle. Release of the 14-kDa-21-kDa protein complex from INV required treatment with the nonionic detergent Nonidet P-40 and a reducing agent. The protein complex consisted of 14-kDa trimers and of 21-kDa dimers. Since the 14-kDa fusion protein lacks a signal sequence and a large hydrophobic domain characteristic of membrane proteins, our findings suggest that the 21-kDa protein serves to anchor the 14-kDa protein to the envelope of INV.

MeSH Terms
Amino Acid Sequence Animals Cells, Cultured Disulfides Genes, Viral/genetics Membrane Proteins Molecular Sequence Data Protein Conformation Protein Processing, Post-Translational Rifampin/pharmacology Vaccinia virus/drug effects,metabolism Viral Envelope Proteins/drug effects,genetics,metabolism Viral Fusion Proteins/drug effects,metabolism Virion/metabolism
Chemicals
A17L protein, Vaccinia virus Disulfides Membrane Proteins Viral Envelope Proteins Viral Fusion Proteins Rifampin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Rodriguez D
Department of Biochemistry, State University of New York, Brooklyn 11203-2098.
Rodriguez J R
Esteban M
References (33)
33 references, click to expand
  1. A simple method for displaying the hydropathic character of a protein.
    J Mol Biol. 1982 May 5;157(1):105-32 PMID: 7108955
  2. Characterization of vaccinia polypeptides.
    Virology. 1981 Aug;113(1):263-76 PMID: 7269242
  3. Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment.
    J Virol. 1985 Sep;55(3):651-9 PMID: 4020961
  4. Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus.
    J Virol. 1985 Nov;56(2):482-8 PMID: 4057358
  5. A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers.
    J Virol. 1987 Feb;61(2):395-404 PMID: 3806791
  6. Isolation and characterization of attenuated mutants of vaccinia virus.
    Virology. 1987 Aug;159(2):408-22 PMID: 3475856
  7. A 14K envelope protein of vaccinia virus with an important role in virus-host cell interactions is altered during virus persistence and determines the plaque size phenotype of the virus.
    Virology. 1987 Aug;159(2):423-32 PMID: 2441522
  8. Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein.
    J Virol. 1987 Nov;61(11):3550-4 PMID: 2822962
  9. Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses.
    Proc Natl Acad Sci U S A. 1989 Feb;86(4):1287-91 PMID: 2784004
  10. A single point mutation of Ala-25 to Asp in the 14,000-Mr envelope protein of vaccinia virus induces a size change that leads to the small plaque size phenotype of the virus.
    J Virol. 1989 Nov;63(11):4507-14 PMID: 2795709
  11. Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein.
    Virology. 1990 Sep;178(1):81-91 PMID: 2389560
  12. Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane.
    J Virol. 1990 Oct;64(10):4884-92 PMID: 2398531
  13. IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress.
    Nucleic Acids Res. 1990 Sep 25;18(18):5347-51 PMID: 2216706
  14. The complete DNA sequence of vaccinia virus.
    Virology. 1990 Nov;179(1):247-66, 517-63 PMID: 2219722
  15. Structural and functional properties of the 14-kDa envelope protein of vaccinia virus synthesized in Escherichia coli.
    J Biol Chem. 1990 Dec 25;265(36):22174-80 PMID: 2266120
  16. Proteolytic maturation of vaccinia virus core proteins: identification of a conserved motif at the N termini of the 4b and 25K virion proteins.
    J Gen Virol. 1991 Feb;72 ( Pt 2):411-6 PMID: 1993877
  17. A mutation in the gene encoding the vaccinia virus 37,000-M(r) protein confers resistance to an inhibitor of virus envelopment and release.
    J Virol. 1991 Jul;65(7):3435-42 PMID: 2041074
  18. The purified 14-kilodalton envelope protein of vaccinia virus produced in Escherichia coli induces virus immunity in animals.
    J Virol. 1991 Oct;65(10):5631-5 PMID: 1654459
  19. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.
    J Virol. 1991 Nov;65(11):5910-20 PMID: 1920620
  20. Subunit interactions of vesicular stomatitis virus envelope glycoprotein stabilized by binding to viral matrix protein.
    J Virol. 1992 Jan;66(1):349-58 PMID: 1309251
  21. Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans.
    J Virol. 1992 Jan;66(1):386-98 PMID: 1727494
  22. Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress.
    J Virol. 1992 Mar;66(3):1610-21 PMID: 1738204
  23. The preparation and characteristics of highly purified radioactively labelled poxvirus.
    Biochim Biophys Acta. 1962 Aug 20;61:290-301 PMID: 14452174
  24. Controlled degradation of vaccinia virions in vitro: an electron microscopic study.
    J Ultrastruct Res. 1966 Mar;14(5):484-96 PMID: 5930347
  25. Formation of a vaccinia virus structural polypeptide from a higher molecular weight precursor: inhibition by rifampicin.
    Proc Natl Acad Sci U S A. 1970 Jul;66(3):677-84 PMID: 5269234
  26. Biogenesis of vaccinia: separation of early stages from maturation by means of rifampicin.
    Virology. 1970 Apr;40(4):1039-51 PMID: 4317898
  27. Events in vaccinia virus-infected cells following the reversal of the antiviral action of rifampicin.
    J Gen Virol. 1970 Dec;9(3):225-37 PMID: 5532240
  28. Assembly of vaccinia virus particles from polypeptides made in the presence of rifampicin.
    Virology. 1971 Jul;45(1):123-34 PMID: 4106980
  29. Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination.
    Virology. 1971 Dec;46(3):507-32 PMID: 4944855
  30. Vaccinia virus reexamined: development and release.
    Virology. 1976 Aug;73(1):43-58 PMID: 960564
  31. Biogenesis of vaccinia: evidence for more than 100 polypeptides in the virion.
    Virology. 1979 Jun;95(2):385-94 PMID: 462799
  32. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia.
    J Gen Virol. 1980 Sep;50(1):89-100 PMID: 7441216
  33. Extracellular release of enveloped vaccinia virus from mouse nasal epithelial cells in vivo.
    J Gen Virol. 1985 Mar;66 ( Pt 3):643-6 PMID: 3973566
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1993-06-00
Pages
3435-40
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC237688
Subset
IM
Grants
NIAID NIH HHS · AI32361 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]